AMENDMENT TO INVESTMENT AGREEMENTInvestment Agreement • June 9th, 2011 • Mabcure Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 9th, 2011 Company IndustryTHIS AMENDMENT TO INVESTMENT AGREEMENT (the “Amendment”) is entered into as of the 2nd day of June, 2011, by and between MabCure, Inc., a Nevada corporation, ("Company"), and Centurion Private Equity, LLC, a Georgia Limited Liability Company (“Investor”).
AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND DEBENTURESecurities Purchase Agreement and Debenture • June 9th, 2011 • Mabcure Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 9th, 2011 Company IndustryTHIS AMENDMENT TO SECURITIES PURCHASE AGREEMENT (the “Amendment”) is entered into as of the 2nd day of June, 2011, by and between MabCure, Inc., a Nevada corporation, ("Company"), and Centurion Private Equity, LLC, a Georgia Limited Liability Company (“Buyer”).